1.Clinical significance of level of CD4+CD25HiCD127Low regulatory T cells in the peripheral blood of patients with esophageal cancers
Kai NIU ; Fucai LIU ; Bin YANG ; Wen SU
Cancer Research and Clinic 2009;21(5):314-316
Objective To detect the levels of CD4+CD25HiCD127Low regulatory T cells (Treg) in the peripheral blood and its clinical significance in patients with esophageal cancer. Methods The levels of Treg in the peripheral blood were detected by three-color flow cytometry (FCM) in 80 patients with esophageal cancer and 20 healthy controls. Among the 80 patients, 30 patients were also further studied for preoperative and postoperative comparison after operation. The clinical and pathological data of each patient were collected and analyzed for the correlation with the Treg levels. Results The level of Treg in the peripheral blood of the control group was lower than that of the esophageal cancer patients [(3.36±1.14) % and (5.70±1.96) %, respectively], with significant difference (P <0.01). The levels of Treg in the peripheral blood was higher in the patients with metastasis of lymph node (n=40) than that in the patients without metastasis of lymph node (5.96±1.36) % and (4.23±1.18) %, respectively] (n=30), with significant difference (P <0.01). The levels of Treg in the peripheral blood of the patients were negatively correlated with their TNM classification. As the TNM classification advanced, the level of the Treg in the peripheral blood increased. Conclusion The levels of Treg in the peripheral blood of the patients with esophageal cancer are significantly higher than that of the healthy subjects, which is correlated with the clinical and pathological conditions. The development of esophageal cancer may relate with suppression of immune function.
2.Clinical significance of CD4+CD25hiCD127low regulatory T cells in the peripheral blood of patients with cardiac cancer
Bin YANG ; Yanfeng WANG ; Rongsheng ZHANG ; Kai NIU ; Xianxia MAI ; Kerong MA ; Wen SU
Cancer Research and Clinic 2010;22(5):303-305
Objective To analyse the dysfunction of immunity and clinical significance in patients with cardiac cancer.Methods The level of CD4+ CD25hi CD127low Treg cells were detected by flow cytometry (FCM),and serum IL-10 and TGF-β1 levels were determined by enzyme linked immunosorbent assay (ELISA) kit in 56 patients with cardiac cancer.15 healthy volunteers were tested as normal controls.The clinical data of each patient were collected and analyzed. Results There was a significantly higher percentage of CD4+ CD25hi CD127low Treg cells in patients with cardiac cancer (5.73±1.56)% than that (4.45±1.06)% of healthy volunteers (P<0.01).The IL-10 and TGF-β1 levels in the serum of patients with cardiac cancer were also significantly higher than that of healthy volunteers (P<0.05).There was a positive correlation between levels of IL-10.TGF-β1 and the levels of CD4+ CD25hi CD127low Treg cells.The number of CD4+ CD25hi CD127low regulatory T cells in the peripheral blood of cardiac cancer patients were significantly correlated with clinical stages and metastasis lymph node.Conclusion The CD4+ CD25hi CD127low Treg cells in the peripheral blood of cardiac cancer patients is significantly increased in comparison with that in healthy volunteers,and was also correlated with different stages.The abnormal levels of CD4+ CD25hi CD127low Treg cells may be related to tumor progression in patients with cardiac cancer.
3.Emergency treatment of ureteric calculi during middle and late pregnancy by ureteroscopy
Hui WEN ; Kai-Yun BIN ; Bing-Fu HUANG ; Kai-Ming CHENG ; Shao-Xiong CHEN ; Yong-Xuan LIANG ; Ji-Qian NIU ; Dai-zhong CHEN ;
Chinese Journal of Urology 2001;0(07):-
Objective To evaluate the efficacy and safety of acute ureteroscopy for the treatment of ureterie stones during middle and late pregnancy.Methods From June 1998 to March 2005,17 pregnant women(mean age,27 years;age range,21-35 years)with ureteric stones were treated by ureteroscopy when the fetus was at 20-36 weeks of gestation(mean,29 weeks).All the cases presented with urgent symptoms such as recurrent renal colic(11 cases),fever(4)or acute obstructive anuria(2).Among 17 cases,the stones(between 6 mm?7 mm and 13 mm?21 mm)were located in the upper(8 cases),middle(5)or lower ureter(4);and on the left side(5 eases),on the right(10)and on both(2)of the lower ureter. Mild hydronephrosis were observed in 6 cases and moderate hydronephrosis in 11,Of the 17 cases,14 under- went ureteroscopic pneumatic lithotripsy;in 1 case the calculi were pushed to the renal pelvis;and 2 cases were treated by Double-J catheter drainage.Results All the urgent symptoms in 17 cases were relieved after treatment.The stone-free rate of initial treatment was 82.4%(14 of 17).Three cases with residual stones were treated by Douhle-J catheters,which were replaced every 3 months until the calculi were re- moved.No abortion,premature delivery or complications such as ureter perforation occurred.Mild renal colic occurred in 1 case after insertion of Douhle-J catheter,and it was relieved 3d later;gross hematuria occurred in l case and disappeared 6 d later without treatment.All 17 patients had normal delivery and gave birth to healthy children.Conclusions Ureteroscopy is a safe and reliable method for the treatment of ureteric calculi during middle and late pregnancy.
4.Effect of the amount of portal blood stasis removal on endotoxemia and liver function after liver transplantation.
Ye WANG ; Jia-mei YANG ; Ming-hua HU ; Dian-qi LI ; Wen-yang NIU ; Peng LIU ; Yuan-kai HOU ; Meng-chao WU
Chinese Journal of Surgery 2008;46(15):1136-1138
OBJECTIVETo investigate the influence of the amount of portal blood stasis removal on endotoxemia and liver function after liver transplantation.
METHODSForty-seven patients who received liver transplantation from February 2006 to November 2007 were divided into 2 groups according to the amount of portal blood stasis removal during operation: group A (n = 26) 50 ml and group B (n = 21) 200 ml of portal blood stasis removal respectively. The levels of plasma endotoxin, D-lactate, tumor necrosis factor-alpha, interleukin-6, liver function and blood coagulation were examined and analyzed.
RESULTSUnder the condition of no significant difference in sex, age, primary liver diseases and Child-pugh's classification, cold ischemic time, total operation and anhepatic time, operation methods, volume of blood loss and transfusion, and all preoperative observations. Most of observations showed the restoration of the patients in group B was better than that in group A. The plasma levels of endotoxin, D-lactate, tumor necrosis factor-alpha, interleukin-6, alanine aminotransferase, aspartate aminotransferase, prothrombin time and activated partial thromboplastin time in group B were significantly lower than those in group A (P < 0.05). The level of plasma prealbumin in group B was significantly higher than that in group A (P < 0.05).
CONCLUSIONSThe removal of 200 ml portal blood stasis leads to a better results than that of 50 ml, and it can help alleviate endotoxemia and facilitate the restoration of the liver function after liver transplantation.
Adult ; Aged ; Bloodletting ; methods ; Endotoxemia ; prevention & control ; Female ; Humans ; Liver ; physiopathology ; Liver Transplantation ; Male ; Middle Aged ; Portal Vein ; surgery ; Postoperative Complications ; prevention & control ; Reperfusion Injury ; prevention & control
5.Case analysis of extensive drug resistant Klebsiella pneumoniae bacteremia treated with tigecycline combined therapy
Jing ZHENG ; Xin YUAN ; Yong-Hui LIU ; Wen-Kai NIU ; Feng-Jiang LI ; Chang-Qing BAI
The Chinese Journal of Clinical Pharmacology 2017;33(8):742-744
Objective To investigate the efficacy of tigecycline in the treatment of bacteremia caused by extensive drug resistant Klebsiella pneumoniae.Methods To analyse a case of extensive drug resistant Klebsiella pneumoniae bacteremia treated with tigecycline combined therapy.Results and conclusion Tigecycline is an option in the combinative treatment of extensive drug resistant Klebsiella pneumoniae bacteremia.
6.Study on pharmacokinetics of cefbuperazone in Chinese healthy volunteers
He-Kun MEI ; Jin WANG ; Rui WANG ; Nan BAI ; Bei-Bei LIANG ; Jiang CAO ; Ming-Jin TANG ; Ken WEN ; Xue-Wei JIANG ; Hui NIU ; Kai WANG
The Chinese Journal of Clinical Pharmacology 2015;(24):2417-2419
Objective To evaluate the pharmacokinetics of cefbupera-zone in Chinese healthy volunteers.Methods The study was designed as an open, randomized, self-control study.12 subjects were received 1.0, 2.0, 3.0 g of cefbuperazone, respectively. Cefbuperazone was determined by high performance liquid chromatography. WinNonlin 5.2.1 software was used to calculate the pharmacokinetic parameters. Results Linear range of cefbuperazone was 2 -250 μg? mL-1 .The main pharmacokinetic parameters of three doses(1.0, 2.0, 3.0 g) of cefbu-perazone were as follows: Cmax were (81.74 ±15.95),(145.47 ±42.22), (198.16 ±36.03)μg? mL-1, tmax were (1.01 ±0.03),(1.02 ±0.04), (1.01 ±0.03), t1/2 were (1.80 ±0.30),(1.88 ±0.31),(1.74 ±0.27), AUC0-t were (136.37 ±43.31), (263.74 ±93.95), (335.76 ±68.47)μg? mL-1? h, respectively. Urinary recovery rate with 16 h was ( 45.24 ±17.50 )%, ( 48.27 ± 15.18 )%, ( 40.82 ± 14.24 )%. Conclusion The characteristic of cefbuperazone is linear.
7.Research progress of a new pharmacokinetics/pharmacodynamic model based on the theory of mutant selection windows
Han ZHANG ; Chang-Qing BAI ; Wen-Kai NIU ; Xin YUAN
The Chinese Journal of Clinical Pharmacology 2018;34(1):89-91
At present,more attention has been paid to the spread of drug -resistant strains caused by the abuse of antibiotics.Comparing to the old model,the new model of pharmacokinetic / pharmacodynamic (PK/PD) which were based on the theory of mutant prevention concentration (MPC) and mutant selection window (MSW),can effectively prevent the emergence of drug-resistant strains by the way of closing or reducing MSW.In this review,we summarized the basic concept and theory of MSW,MPC as well as its application in guiding the establishment of new PK/PD model,hoping to provide references for the rational use of antibiotics and inhibiting the emergence of drug-resistant mutant strains.
8.Early hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: the risk factors and long-time survival.
Ming BAI ; Guo-hong HAN ; Shan-shan YUAN ; Zhan-xin YIN ; Chuang-ye HE ; Jian-hong WANG ; Xing-shun QI ; Jing NIU ; Wen-gang GUO ; Kai-Chun WU ; Dai-Ming FAN
Chinese Journal of Hepatology 2011;19(7):498-501
OBJECTIVETo identify the risk factors of early post-TIPS hepatic encephalopathy (HE) and the long-time survival of patients with or without early post-TIPS HE.
METHODSConsecutive cirrhotic patients who underwent TIPS for variceal rebleeding or refractory ascites in our center from January 2003 to December 2008 were included in this study. More than 60 clinical characteristics were enrolled in univariate analysis and logistic regression analysis to define the risk factors of HE in 3 months after TIPS procedure (early post-TIPS HE). The long-time survival of patients with or without early post-TIPS HE was compared by Cox regression with several covariates.
RESULTSAccording to our inclusion criteria, 190 patients were included. The median follow-up was 30.5 months. Lower serum concentration of fibrinogen and higher Child-Pugh score were the independent risk factors for suffering early post-TIPS HE. Patients without early post-TIPS HE after TIPS showed better prognosis than those with early post-TIPS HE after TIPS (P = 0.044).
CONCLUSIONPatients with lower serum fibrinogen and higher Child-Pugh score before TIPS might be more probably attacked by early post-TIPS HE which indicated worse long-term survival.
Adult ; Female ; Fibrinogen ; analysis ; Follow-Up Studies ; Hepatic Encephalopathy ; diagnosis ; etiology ; Humans ; Male ; Middle Aged ; Portasystemic Shunt, Transjugular Intrahepatic ; adverse effects ; Prognosis ; Risk Factors
9.Diagnostic role of BIOMED-2 multiplex polymerase chain reaction for antigen receptor genes rearrangement in lymphoproliferative disorders.
Yan-Ling LIU ; Mei HUANG ; Deng-Ju LI ; Yi XIAO ; Yi TANG ; Fan-Kai MENG ; Jin-Niu DENG ; Han-Ying SUN ; Wen-Li LIU ; Jian-Feng ZHOU
Chinese Journal of Hematology 2009;30(4):251-254
OBJECTIVETo establish a sensitive and effective method for detection of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangement,and to explore its role in diagnosis and differential diagnosis of lymphoproliferative disorders.
METHODSFifty-eight lymphoid tissue samples from 54 patients with lymphoproliferations were evaluated by the novel BIOMED-2 multiplex polymerase chain reaction (PCR) for antigen receptor genes rearrangement.
RESULTSMultiplex PCR demonstrated monoclonal Ig/TCR gene rearrangements in 22 of 25 (88.0%) B-cell malignancies and 8 of 15 (53.3%) T-cell malignancies. Among 17 benign lymphoproliferations confirmed histopathologically, polyclonal rearrangements were detected in 14 cases (82.4%). In total, the clonality analysis and the final clinico-histopathological diagnosis were concordant in 77.2%. Combination detection of Iglambda and TCR delta gene rearrangements did not increase the detection rate of monoclonal rearrangement of Ig/TCR, but might help to the detection of Iglambda+ or TCR delta+ lymphomas.
CONCLUSIONThe novel BIOMED-2 multiplex PCR strategy is a rapid, reliable and sensitive approach to detecting clonality in suspected lymphoproliferations, especially in atypical cases.
Female ; Gene Rearrangement, B-Lymphocyte, Light Chain ; Gene Rearrangement, T-Lymphocyte ; Humans ; Lymphoproliferative Disorders ; diagnosis ; genetics ; Male ; Polymerase Chain Reaction ; methods ; Sensitivity and Specificity
10.Circulating endothelial cells in the peripheral blood of advanced NSCLC patients.
Chun HUANG ; Kai LI ; Xi-Yin WEI ; Rui-Fang NIU ; Yan SUN ; Jin-Wan WANG ; Yun-Zhong ZHU ; Li-Yan XU ; Xiao-Qing LIU ; Hong-Jun GAO ; Jing-Min ZHOU ; Xiu-Wen WANG
Chinese Journal of Oncology 2006;28(10):780-783
OBJECTIVETo investigate the changes and clinical value of circulating endothelial cells (CEC) in the peripheral blood of advanced NSCLC patient.
METHODSSixty-seven advanced NSCLC patients were randomly divided into either the treatment group with NP plus endostatin or control group with NP alone. Level of CEC and cytokeratin (CK) in the peripheral blood were measured by flow cytometry.
RESULTSThe response rate and benefit rate was 44.4%, 80.0% in the treatment group, and 27.3%, 50.0% in the control group, respectively (P = 0.176 and P = 0.012). Time to tumor progression (TTP) was 146.7 days in the treatment group and 91.1 days in the control group (P = 0.061). However, when the cut-off of TTP was defined as > 170 days, there was a significant difference between two groups (cut-off = 170, P = 0.034; cut-off = 180, P = 0.009). The number of CEC decreased by 0.29 +/- 0.47 in the treatment group and by 0.01 +/- 0.43 in the control group (P = 0.033). The correlation between CEC and CK was found to be positive either before (r = 0.381, P = 0.013) or after the treatment (r = 0.450, P = 0.004).
CONCLUSIONChemotherapy combined with endostatin is superior to chemotherapy alone in the treatment of NSCLC. CEC, as a biomarker, may be useful in predicting the efficacy of the combined treatment.
Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Carcinoma, Non-Small-Cell Lung ; blood ; drug therapy ; pathology ; Cell Count ; Cisplatin ; administration & dosage ; Endostatins ; administration & dosage ; Endothelial Cells ; pathology ; Endothelium, Vascular ; pathology ; Female ; Flow Cytometry ; Follow-Up Studies ; Humans ; Keratins ; blood ; Lung Neoplasms ; blood ; drug therapy ; pathology ; Male ; Middle Aged ; Neoplastic Cells, Circulating ; pathology ; Remission Induction ; Treatment Outcome ; Vinblastine ; administration & dosage ; analogs & derivatives